Accendra Health Inc.
- ACH ยท NYSE
- Wholesale-Medical, Dental & Hospital Equipment & Supplies
- Glen Allen, VA
- 6,500 employees
- CIK 0000075252
Updated from SEC filings through
Top things to know
Executives
- Kenneth Gardner-Smith President & CEO 4, 2026-10-06
- Andrew G. Long EVP, CEO P&HS 4, 2025-11-20
- Jonathan A. Leon EVP & CFO 4, 2026-09-24
- Scott MacRae Lloyd EVP, Chief Commercial Officer 3, 2026-11-04
- Perry A. Bernocchi EVP, Chief Operating Officer 4, 2026-05-19
- Perry Bernocchi Executive Vice President & Chief Operating Officer 10-K, 2026-02-20
What leadership is saying
“Over the several weeks since I started, a number of themes have become clear to me. We have strong brands, favorable end markets, and a teammate population dedicated to our mission, Bringing Care To Life. It is equally clear to me that our results to date in 2026 have fallen well short of our expectations and potential. We have identified four key areas which are critical to our continued transformation and returning the business to the kind of profitability that our sharehol”
Earnings press release (8-K Ex. 99.1), filed November 5, 2026
Accendra Health Inc is a U.S. public company in wholesale-medical, dental & hospital equipment & supplies (SIC 5047), headquartered in Glen Allen, VA. It trades as ACH on NYSE. Revenue was $2.8B in the fiscal year ending December 31, 2025, +3.1% from the year before. It reported about 6,500 employees. Kenneth Gardner-Smith is President & CEO.
Five-year financials
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $2.8B 10-K, 2026-02-20 | $2.7B 10-K, 2026-02-20 | $2.6B 10-K, 2026-02-20 | $10.0B 10-K, 2025-02-28 | $9.8B 10-K, 2024-02-20 |
| Operating income | $27.5M 10-K, 2026-02-20 | -$218M 10-K, 2026-02-20 | $133M 10-K, 2026-02-20 | $143M 10-K, 2025-02-28 | $368M 10-K, 2024-02-20 |
| SG&A | $1.1B 10-K, 2026-02-20 | $1.1B 10-K, 2026-02-20 | $1.0B 10-K, 2026-02-20 | $1.6B 10-K, 2025-02-28 | $1.1B 10-K, 2024-02-20 |
| Net income | -$1.1B 10-K, 2026-02-20 | -$363M 10-K, 2026-02-20 | -$41.3M 10-K, 2026-02-20 | $22.4M 10-K, 2025-02-28 | $222M 10-K, 2024-02-20 |
Annual figures from XBRL in each company's own filings. Click a figure to open the filing. SG&A marked derived is general and administrative plus selling and marketing.
Leadership and board
| Name | Title | Source |
|---|---|---|
| Kenneth Gardner-Smith | President & CEO | 4, 2026-10-06 |
| Andrew G. Long | EVP, CEO P&HS | 4, 2025-11-20 |
| Jonathan A. Leon CFO | Reshaped a 140-year-old distributor into a direct-to-patient leader | $700M deleveraging and $4.1B raised | M&A, Capital Markets, Investor Relations | EVP & CFO | 4, 2026-09-24 |
| Scott MacRae Lloyd | EVP, Chief Commercial Officer | 3, 2026-11-04 |
| Perry A. Bernocchi | EVP, Chief Operating Officer | 4, 2026-05-19 |
| Perry Bernocchi | Executive Vice President & Chief Operating Officer | 10-K, 2026-02-20 |
| Heath H. Galloway | EVP,General Counsel & CorpSecy | 4, 2026-05-20 |
| Gwendolyn M. Bingham | Board member (per proxy) bio: Independent Director | DEF 14A, 2026-04-02 |
| Mark A. Beck | Board member (per proxy) bio: Chair of the Board | DEF 14A, 2026-04-02 |
What Accendra Health Inc does
Accendra Health, Inc. (f/k/a Owens & Minor, Inc.) and subsidiaries (Accendra Health, we, us, our or the Company) is a leading nationwide provider of products, technology, and services that supports health beyond the hospital for millions of people each year. We connect patients, providers, and insurers, delivering innovative solutions that help promote better health outcomes and improve quality of life for people living with chronic, complex, and acute health conditions.
Item 1. Business, 10-K for the year ending December 31, 2025
Shares and governance
| Shares outstanding | 76.9 million (as of September 30, 2026) | 10-Q, November 6, 2026 |
|---|---|---|
| Public float | $678M (as of June 30, 2025) | 10-K, February 20, 2026 |
| Reportable segments | 1 (period ending September 30, 2026) | 10-Q, November 6, 2026 |
| Latest proxy statement | Meeting December 1, 2026 (filed October 29, 2026) | DEF 14A, October 29, 2026 |
| Auditor | Kpmg, LLP (Richmond, VA) | Latest 10-K |
Recent 8-K events
- 8-K filed 2026-11-05
- Item 2.02 Results of operations and financial condition (earnings release)
- Item 7.01 Regulation FD disclosure
- 8-K filed 2026-11-03
- Item 5.02 Departure or appointment of directors or officers; compensation
- 8-K filed 2026-11-02
- Item 1.01 Entry into a material definitive agreement
- Item 7.01 Regulation FD disclosure
- 8-K filed 2026-10-30
- Item 3.01 Notice of delisting or failure to meet listing standards
- Item 7.01 Regulation FD disclosure
- 8-K filed 2026-10-09
- Item 3.01 Notice of delisting or failure to meet listing standards
- Item 7.01 Regulation FD disclosure
- 8-K filed 2026-09-17
- Item 5.02 Departure or appointment of directors or officers; compensation
- Item 7.01 Regulation FD disclosure
- Item 8.01 Other events
- 8-K filed 2026-08-17
- Item 7.01 Regulation FD disclosure
- 8-K filed 2026-08-10
- Item 1.01 Entry into a material definitive agreement
- Item 3.03 Material modification to rights of security holders
- Item 5.03 Amendments to articles or bylaws; change in fiscal year
- Item 7.01 Regulation FD disclosure
- 8-K filed 2026-08-10
- Item 2.02 Results of operations and financial condition (earnings release)
- Item 7.01 Regulation FD disclosure
- 8-K filed 2026-08-10
- Item 5.02 Departure or appointment of directors or officers; compensation
- Item 7.01 Regulation FD disclosure
Frequently asked questions about Accendra Health Inc
- What does Accendra Health Inc do?
- In its own words, from Item 1 of its 10-K: "Accendra Health, Inc. (f/k/a Owens & Minor, Inc.) and subsidiaries (Accendra Health, we, us, our or the Company) is a leading nationwide provider of products, technology, and services that supports health beyond the hospital for millions of people each year. We connect patients, providers, and insurers, delivering innovative solutions that help promote better health outcomes and improve quality of life for people living with chronic, complex, and acute health conditions."
- What is Accendra Health Inc's revenue?
- $2.8B for the fiscal year ending December 31, 2025, from its 10-K filed February 20, 2026.
- Is Accendra Health Inc profitable?
- Accendra Health Inc reported net income of -$1.1B for the fiscal year ending December 31, 2025.
- How many employees does Accendra Health Inc have?
- About 6,500, as stated in its annual report.
- Who is the CEO of Accendra Health Inc?
- Kenneth Gardner-Smith, President & CEO, as named in a 4 filed October 6, 2026.
- Who is the CFO of Accendra Health Inc?
- Jonathan A. Leon, EVP & CFO, as named in a 4 filed September 24, 2026.
- Where is Accendra Health Inc headquartered?
- Glen Allen, VA.
- What is Accendra Health Inc's stock ticker?
- ACH on NYSE.
- What industry is Accendra Health Inc in?
- Wholesale-Medical, Dental & Hospital Equipment & Supplies, SIC code 5047.
- What is Accendra Health Inc's website?
- accendrahealth.com.
- When does Accendra Health Inc report earnings next?
- November 9, 2026. Source: estimate_8k_pattern.
- Is Accendra Health Inc a public company?
- Yes. Accendra Health Inc files with the SEC under CIK 0000075252 and trades as ACH.
- Who audits Accendra Health Inc?
- Kpmg, LLP, Richmond, VA, as named in its latest annual report (10-K).
- How many shares of Accendra Health Inc are outstanding?
- 76.9 million shares as of September 30, 2026, from its 10-Q filed November 6, 2026.
- What is Accendra Health Inc's public float?
- $678M as of June 30, 2025, as reported on the cover of its 10-K filed February 20, 2026.
- How many business segments does Accendra Health Inc report?
- 1 reportable segment for the period ending September 30, 2026, from its 10-Q filed November 6, 2026.
- When is Accendra Health Inc's annual shareholder meeting?
- December 1, 2026, per its proxy statement (DEF 14A) filed October 29, 2026.